Aminoacylase 1 (ACY1) has been implicated as a putative tumor suppressor in a variety of carcinomas, including small-cell lung cancer [11], renal clear cell carcinoma [12], hepatocellular carcinoma [13], and neuroblastoma [10]. Here, ACY1 is linked to clear cell renal carcinoma.